Feasibility of a Home Exercise Program to Manage Post-transplant Metabolic Syndrome
Metabolic Syndrome
About this trial
This is an interventional treatment trial for Metabolic Syndrome focused on measuring Lung Transplant Recipients, Liver Transplant Recipients, Exercise Training
Eligibility Criteria
Inclusion Criteria:
- Adult lung and liver transplant recipients 12 to 18 months post-transplant
- Presence of 2 or more metabolic risk factors (hypertension, hyperlipidemia, diabetes, obesity)
Exclusion Criteria:
- Active cardiovascular disease (recent heart attack, significant coronary artery disease on cardiac catheterization, heart failure, uncontrolled arrhythmias, chest pain, dizziness, or fainting in the last 3 months)
- Neuro-muscular disease or orthopedic limitations
- Physically active with ≥ 150 minutes/week of moderate-intensity aerobic physical activity
Sites / Locations
- University Health Network - Toronto General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Home Exercise Group
Control Group
The home-based exercise group will be asked to exercise 3 to 5 times per week (≥ 150 minutes of aerobic exercises (i.e. walking, cycling, or treadmill) of at least moderate intensity) and to also complete resistance training (resistance bands or free weights) at least twice weekly over a 12-week period supervised by an exercise professional. The resistance training will be personalized, aiming for 6 to 10 exercises targeting the major muscle groups, progressing to 3 sets of 8 to 12 repetitions. Exercise prescriptions will be developed and monitored by an exercise professional with weekly follow-up meetings and supported with a web application (Physiotec) that allows customizable exercise prescriptions, tracking of exercise completion, and video tutorials. Participants will receive one counselling session on healthy eating and physical activity at the start of the study along with an exercise manual.
Participants will receive one counselling session on healthy eating and physical activity at the start of the study.